Author Guidelines

NOVAXIS

Author Guidelines

NOVAXIS is an international, peer-reviewed, open-access journal dedicated to frontier research in science and technology, with particular emphasis on artificial intelligence, quantum systems, future materials, human–machine frontiers, and emerging areas created through their convergence.

Authors should read the Aims and Scope carefully before submission and clearly explain both the immediate contribution of their work and its significance for an emerging scientific or technological direction.

NOVAXIS welcomes both disciplinary and interdisciplinary research. A manuscript does not need to combine multiple fields to be considered. However, it must demonstrate a significant advance, introduce a new scientific or technological capability, provide compelling new evidence or insight, or show clear relevance to an emerging technological frontier. Incremental applications of established methods without a substantive contribution are unlikely to proceed to external peer review.

1. Article Types

Research Article

Research Articles report original theoretical, computational, experimental, or empirical research that makes a substantial scientific or technological contribution. A typical Research Article is approximately 5,000–10,000 words, excluding references, figure captions, tables, declarations, and supplementary material.

Review Article

Review Articles provide critical and structured analyses of rapidly developing fields. They should go beyond descriptive summaries by synthesising existing knowledge, identifying major debates and unresolved problems, establishing useful classifications or conceptual frameworks, and outlining important future research directions. A typical Review Article is approximately 8,000–15,000 words.

Perspective

Perspective articles provide forward-looking and evidence-based analyses of emerging scientific or technological directions. They may introduce a new conceptual position, identify an important frontier, evaluate the implications of a developing technology, or propose a research agenda. A typical Perspective is approximately 3,000–6,000 words.

Methods and Technical Article

Methods and Technical Articles introduce important experimental methods, computational frameworks, system architectures, research platforms, datasets, protocols, evaluation procedures, or enabling technologies. The scientific usefulness and technical validity of the proposed method or system should be demonstrated. A typical Methods and Technical Article is approximately 4,000–8,000 words.

The recommended word limits are flexible. Authors should prioritise scientific substance, clarity, and completeness rather than unnecessary length.

2. Editorial Criteria

All manuscripts undergo an initial editorial assessment before external peer review. The editors evaluate whether the manuscript is appropriate for NOVAXIS and whether it meets the journal's expectations for originality, scientific significance, methodological rigour, technical credibility, and relevance to an emerging research frontier.

Manuscripts suitable for NOVAXIS should normally demonstrate several of the following characteristics:

• a clearly defined scientific or technological problem;
• a substantial contribution beyond the current state of the art;
• strong theoretical, computational, experimental, or empirical support;
• appropriate comparisons with meaningful baseline methods or existing approaches;
• transparent methods that permit independent scientific evaluation;
• evidence that reported improvements are scientifically or practically meaningful rather than marginal numerical differences;
• clear identification of limitations and boundary conditions;
• relevance to an emerging scientific or technological direction;
• where interdisciplinary, a substantive contribution created through the integration of different disciplines.

Routine applications of established methods, minor algorithmic optimisation, superficial combinations of existing technologies, descriptive case studies with limited scientific generalisability, and manuscripts whose conclusions substantially exceed the evidence presented may be rejected during initial editorial screening.

3. Submission Requirements

Manuscripts must be submitted through the official NOVAXIS online submission system.

A complete initial submission should normally include:

• the main manuscript;
• a title page containing complete author information;
• a cover letter;
• figures and tables where applicable;
• supplementary materials where applicable;
• a Data Availability Statement;
• a Conflict of Interest Statement;
• a Funding Statement;
• an Author Contributions Statement;
• a declaration regarding the use of generative AI or AI-assisted technologies where applicable.

The title page should include the manuscript title, full names of all authors, institutional affiliations, corresponding author information, email address, and ORCID iD where available.

The cover letter should briefly explain the principal contribution of the manuscript, its relevance to NOVAXIS, the area of the journal's scope to which it contributes, and any closely related manuscripts, conference versions, preprints, or previous versions of the work.

4. Manuscript Preparation

Manuscripts must be written in clear academic English. Either British or American English may be used, but spelling and language conventions should remain consistent throughout the manuscript.

Authors are encouraged to use the official NOVAXIS manuscript template where available. Manuscripts should use a clear standard font, continuous page numbering, and formatting that allows editors and reviewers to assess the work efficiently.

A standard Research Article should normally contain the following sections:

1. Title
2. Authors and Affiliations
3. Abstract
4. Keywords
5. Introduction
6. Related Work or Background, where appropriate
7. Materials and Methods, Methodology, or System Design
8. Results
9. Discussion
10. Conclusion
11. Declarations
12. Acknowledgements, where applicable
13. References

The exact structure may be adapted to disciplinary conventions. However, the research objective, methodology, evidence, principal findings, limitations, and contribution should be readily identifiable.

5. Title, Abstract and Keywords

Title

The title should be concise, informative, specific, and representative of the principal contribution of the manuscript.

Authors should avoid unnecessary abbreviations, excessively broad claims, promotional wording, and unsupported expressions such as "groundbreaking", "revolutionary", or "the first" unless such statements can be objectively demonstrated.

Abstract

Research Articles should normally contain an abstract of approximately 150–250 words.

The abstract should briefly identify the research problem or objective, describe the principal methodology or approach, present the main results, and explain the significance of the findings.

The abstract should be understandable without reference to the main manuscript and should normally avoid citations, unexplained abbreviations, equations, and excessive technical detail.

Keywords

Authors should provide 4–8 keywords that accurately represent the principal concepts, methods, technologies, systems, or application domains addressed in the manuscript.

6. Introduction

The Introduction should establish the scientific or technological context of the study, identify the relevant research gap, explain why the problem is important, and state the objective or research question clearly.

The final part of the Introduction should normally explain the principal contribution of the manuscript and how it advances existing knowledge or technology.

Authors should avoid unnecessarily broad literature summaries that do not directly support the research problem.

7. Methods and Reproducibility

Methods must be described in sufficient detail to allow qualified researchers to evaluate the validity of the work and, where reasonably possible, reproduce the study.

Authors should report all information necessary to interpret the results, including relevant experimental conditions, model architectures, datasets, parameter settings, hardware or computational environments, preprocessing procedures, evaluation metrics, statistical methods, and exclusion criteria where applicable.

Computational and Artificial Intelligence Research

For computational, machine learning, and artificial intelligence studies, authors should report relevant information including:

• the source and composition of training, validation, and test datasets;
• data collection, preprocessing, cleaning, and sampling procedures;
• model architecture and important hyperparameters;
• training procedures;
• software frameworks and important software versions;
• computational hardware used for major experiments;
• evaluation metrics;
• baseline or comparison methods;
• random seeds or repeated-run procedures where relevant;
• ablation studies or sensitivity analyses where needed;
• measures of uncertainty, variability, or statistical significance where applicable.

Experimental Research

Experimental studies should provide sufficient information regarding materials, equipment, experimental protocols, calibration, measurement procedures, environmental conditions, controls, sample sizes, and statistical analyses to support independent assessment of the findings.

Quantum Research

Quantum computing, quantum information, quantum sensing, and related studies should describe the theoretical assumptions, computational or physical platform, circuit or system configuration, noise assumptions, benchmarking procedures, measurement methods, and relevant hardware or simulation environment where applicable.

Materials Research

Materials research should report relevant preparation or fabrication procedures, characterisation methods, measurement conditions, computational parameters, structural information, validation procedures, and sufficient evidence to support claims concerning material properties or performance.

8. Results

The Results section should present the principal findings clearly and objectively.

Authors should distinguish observed results from their interpretation and avoid repeating the same information extensively in the text, tables, and figures.

Quantitative results should be accompanied by appropriate measures of uncertainty, variation, effect magnitude, or statistical significance where relevant.

Negative, null, or unexpected findings should not be omitted when they are important for interpreting the study.

9. Discussion

The Discussion should interpret the results in relation to the research question, existing literature, and broader scientific or technological context.

Authors should explain what the findings demonstrate, how they differ from or extend previous work, and why they matter.

The Discussion should distinguish findings supported directly by the presented evidence from broader interpretations or future possibilities.

Limitations, uncertainties, and important boundary conditions should be discussed explicitly.

10. Conclusion

The Conclusion should summarise the principal contribution and implications of the study without simply repeating the Abstract or Results.

Claims about future applications or broader impact should remain proportional to the evidence presented in the manuscript.

11. Data, Code and Research Materials

Every manuscript must include a Data Availability Statement explaining whether and how the data supporting the findings can be accessed.

NOVAXIS strongly encourages authors to make research data, source code, trained models, experimental protocols, simulation configurations, benchmark datasets, and other materials required for independent verification publicly available whenever ethical, legal, security, intellectual property, and commercial considerations permit.

Research materials should preferably be deposited in a recognised repository that provides a persistent identifier or stable public access.

Where materials cannot be made publicly available, authors must state the reason clearly. Restrictions may include participant privacy, legal requirements, intellectual property obligations, national security considerations, or legitimate commercial confidentiality.

If data are available only upon reasonable request, the Data Availability Statement should identify the conditions under which access may be granted.

12. Figures

Figures should be scientifically accurate, visually clear, and legible at publication size.

Authors should:

• number figures consecutively according to their first citation in the manuscript;
• provide an informative caption for every figure;
• define symbols, abbreviations, colours, and line styles where necessary;
• ensure that labels remain readable when figures are reduced for publication;
• avoid unnecessary decorative graphics;
• avoid misleading scales, axes, or graphical representations;
• identify reproduced or adapted material appropriately;
• obtain copyright permission where required.

Raster images should normally have a minimum resolution of approximately 300 dpi. Line drawings and diagrams should normally be prepared at a higher resolution where necessary to maintain publication quality.

13. Tables

Tables should present information efficiently and should not substantially duplicate information already provided in the text or figures.

Tables must be numbered consecutively and cited in the manuscript in numerical order.

Each table should have a concise title. Abbreviations, statistical notation, symbols, and other information necessary for interpretation should be explained clearly.

Very large tables may be moved to supplementary material where appropriate.

14. Equations, Symbols and Units

Important equations should be numbered consecutively when they are referred to elsewhere in the manuscript.

Variables, mathematical symbols, operators, and specialised notation should be defined when first introduced.

SI units should be used wherever applicable. Alternative units may be provided when conventional within a particular field, but usage must remain consistent.

15. Statistical Reporting and Quantitative Claims

Authors should report quantitative results with sufficient information for readers to evaluate the strength, uncertainty, and scientific significance of the evidence.

Where appropriate, manuscripts should report:

• sample sizes;
• measures of variation;
• confidence intervals;
• effect sizes;
• statistical tests;
• assumptions underlying statistical procedures;
• corrections for multiple comparisons where applicable;
• exact probability values where appropriate.

Authors should avoid relying exclusively on whether a result reaches a conventional threshold of statistical significance.

Benchmark improvements should be interpreted in context. Small numerical differences should not be described as major technological advances unless their practical or scientific significance is clearly demonstrated.

16. References

NOVAXIS uses a numbered reference system. References should be numbered consecutively according to their first appearance in the manuscript.

Authors are responsible for ensuring that all references are accurate, complete, relevant, and traceable.

DOI identifiers should be included wherever available.

Authors should:

• cite original sources for important methods, theories, datasets, algorithms, software, and scientific claims;
• use recent and authoritative literature where appropriate;
• avoid unnecessary or excessive self-citation;
• avoid citation manipulation;
• avoid references included primarily to increase citation counts;
• cite the published version of a work when an authoritative published version is available;
• identify preprints clearly when cited;
• cite datasets, software, standards, repositories, and research infrastructure formally where appropriate.

Every source cited in the manuscript must appear in the reference list, and every reference-list entry must be cited in the manuscript.

Authors should verify all references before submission. Incorrect, fabricated, inaccessible, or unverifiable references may result in editorial queries or rejection.

17. Authorship and Author Contributions

Authorship should be limited to individuals who have made substantial intellectual contributions to the work, participated in drafting or critically revising the manuscript, approved the version submitted for publication, and agree to be accountable for their contribution.

Honorary authorship, guest authorship, purchased authorship, and ghost authorship are not permitted.

Individuals who contributed to the work but do not meet the criteria for authorship should be acknowledged appropriately.

Every manuscript must include an Author Contributions Statement. Authors are encouraged to use the CRediT Contributor Roles Taxonomy where applicable.

The corresponding author is responsible for communication with the journal and should confirm that all authors have approved the manuscript and agreed to its submission.

The corresponding author should provide an ORCID iD. ORCID iDs are strongly encouraged for all authors.

Requests to add, remove, or rearrange authors after submission must include a clear explanation and normally require written agreement from all affected authors.

Changes to authorship after acceptance will be permitted only in exceptional circumstances and require editorial approval.

18. Use of Artificial Intelligence and Generative AI

Artificial intelligence systems, large language models, generative AI systems, and other automated tools cannot be listed as authors because they cannot take responsibility for the integrity, originality, or accuracy of scholarly work.

Authors who use generative AI or AI-assisted technologies in preparing a manuscript must disclose such use when the technology has materially contributed to substantive text, code, figures, images, data processing, analysis, translation, literature synthesis, or other research content.

The declaration should identify the tool used and explain the purpose for which it was used.

Routine spelling correction, grammar checking, reference management, and similar assistive functions that do not generate substantive scholarly content generally do not require detailed disclosure.

Authors remain fully responsible for all AI-assisted content, including:

• factual accuracy;
• scientific interpretation;
• references and citations;
• computer code;
• statistical analysis;
• figures and images;
• originality;
• confidentiality;
• copyright compliance;
• research ethics.

AI-generated references must be independently verified by the authors. Fabricated, incorrect, or unverifiable references may constitute grounds for rejection or post-publication action.

19. Research Involving Humans or Animals

Human Participants

Research involving human participants, identifiable human data, human biological materials, or interventions involving human subjects must comply with relevant institutional, national, and international ethical requirements.

Where applicable, manuscripts must identify the approving ethics committee or institutional review board and provide the approval or protocol number where available.

Authors must explain how informed consent was obtained where applicable.

If formal ethical approval was not required, the manuscript should explain the applicable exemption or institutional basis for this determination.

Animal Research

Research involving animals must comply with applicable institutional and national animal-welfare regulations and internationally recognised ethical principles.

The manuscript should identify the approving authority and relevant protocol information where applicable.

20. Safety, Dual Use and Emerging Technology Risks

Because NOVAXIS publishes research involving rapidly developing technologies, authors should consider whether their work creates material safety, security, privacy, environmental, societal, or dual-use risks.

Examples may include highly autonomous AI systems, cybersecurity-sensitive technologies, advanced biological interfaces, neurotechnology, quantum-enabled security technologies, human augmentation, and other technologies capable of harmful misuse.

Where significant risks are reasonably foreseeable, manuscripts should discuss appropriate safeguards, limitations, responsible-use considerations, access controls, or risk-mitigation approaches.

The editors may request additional information or limit publication of operational details where unrestricted disclosure could create a substantial and credible risk of harm.

21. Conflicts of Interest

All authors must disclose financial and non-financial interests that could reasonably be perceived as influencing the research, interpretation of the findings, or publication process.

Relevant competing interests may include:

• employment;
• consultancy;
• stock ownership;
• patents;
• advisory positions;
• research sponsorship;
• paid expert testimony;
• financial relationships;
• relevant personal or professional relationships.

If no competing interests exist, authors should include a statement confirming that they have no conflicts of interest to declare.

22. Funding

All sources of financial support must be disclosed.

Funding statements should provide the full name of the funding organisation and grant number where available.

Authors should also disclose whether the funder had any role in study design, data collection, analysis, interpretation, manuscript preparation, or the decision to submit the manuscript for publication.

23. Originality and Prior Publication

Submission to NOVAXIS confirms that the manuscript presents original scholarly work and has not previously been published as a peer-reviewed journal article.

A manuscript must not be simultaneously under consideration by another journal.

Duplicate publication, redundant publication, substantial unattributed overlap, plagiarism, inappropriate text recycling, fabrication, falsification, and manipulation of research records are not permitted.

All submissions may be screened using similarity-detection or other research-integrity tools.

24. Preprints

Posting a manuscript on a recognised preprint server does not normally constitute prior publication and does not prevent submission to NOVAXIS.

Authors should disclose the existence of a preprint during submission and provide its identifier, DOI, or other persistent link where available.

If the manuscript is published in NOVAXIS, authors are encouraged to update the preprint record to provide a link to the final published article where permitted by the relevant repository.

25. Conference Papers and Extended Versions

Extended versions of conference papers may be considered when the submitted manuscript contains a substantial amount of new scholarly content beyond the conference publication.

Authors must disclose the previous conference publication, cite it appropriately, and explain clearly how the submitted journal manuscript extends the earlier work.

The extended manuscript should normally contain meaningful new analysis, methods, experiments, theoretical development, datasets, results, or interpretation rather than only cosmetic changes.

26. Research Integrity

NOVAXIS is committed to maintaining the integrity of the scholarly record.

Authors must not fabricate or falsify data, manipulate figures in a misleading manner, conceal important methodological information, misrepresent results, manipulate citations, interfere improperly with peer review, or provide false information during submission.

Suspected research misconduct may be investigated before or after publication.

Where necessary, the journal may issue corrections, expressions of concern, retractions, or other appropriate editorial notices to protect the integrity of the scholarly record.

27. Image Integrity

Images must accurately represent the original data.

Adjustments to brightness, contrast, colour balance, or other image properties are acceptable only when applied consistently and when they do not obscure, eliminate, introduce, or misrepresent information.

Images assembled from multiple experiments, samples, or fields should be labelled clearly.

The editorial office may request original, unprocessed image files where image integrity requires verification.

28. Peer Review

NOVAXIS operates a single-anonymised peer-review process. Author identities are visible to reviewers, while reviewer identities are not normally disclosed to authors.

Manuscripts that pass initial editorial screening are normally evaluated by at least two independent reviewers with appropriate expertise.

Reviewers are asked to assess:

• originality and significance;
• scientific and technical soundness;
• adequacy of the methodology;
• quality and sufficiency of the evidence;
• reproducibility and transparency;
• appropriate interpretation of the findings;
• relevance to the Aims and Scope of NOVAXIS;
• clarity and quality of presentation;
• appropriate acknowledgement of limitations;
• for interdisciplinary work, whether convergence produces a genuine scientific or technological contribution.

Editorial decisions may include acceptance, minor revision, major revision, or rejection.

The Editor-in-Chief or handling editor makes the final editorial decision based on the manuscript, reviewer reports, author responses, research-integrity considerations, and the editorial standards of NOVAXIS.

29. Reviewer Suggestions

Authors may be invited to suggest potential reviewers during submission.

Suggested reviewers should have appropriate expertise and should be independent of the authors and the submitted work.

Authors should not suggest individuals with recent collaborations, close institutional relationships, significant personal relationships, direct supervisory relationships, or other substantial conflicts of interest.

The editorial office is under no obligation to invite author-suggested reviewers.

30. Revised Submissions

Authors submitting a revised manuscript must provide a detailed point-by-point response to all comments raised by the editors and reviewers.

The response should:

• identify each reviewer or editorial comment clearly;
• explain how each comment has been addressed;
• identify where corresponding changes appear in the revised manuscript;
• provide a clear scientific explanation where the authors do not adopt a requested change.

Responses should remain professional, evidence-based, and focused on improving the manuscript.

Substantive modifications should be clearly identifiable in the revised manuscript unless the editorial office provides alternative instructions.

31. Supplementary Material

Supplementary material may include additional methods, figures, tables, videos, datasets, mathematical derivations, experimental procedures, model specifications, extended validation results, source code documentation, or other information supporting the article.

Supplementary material should be relevant to the published research, clearly labelled, and cited from the main manuscript where appropriate.

Supplementary files form part of the scholarly publication and must therefore meet appropriate standards of accuracy and research integrity.

32. Copyright Permissions

Authors are responsible for obtaining permission to reproduce copyrighted material from other publications or sources where permission is legally required.

Previously published figures, tables, substantial text, images, instruments, or other protected material should be credited appropriately.

Authors must provide documentation of permissions if requested by the editorial office.

33. After Acceptance

Accepted manuscripts proceed to editorial production, which may include copyediting, typesetting, metadata preparation, proof generation, and final publication processing.

Authors will receive proofs for final checking and should return requested corrections within the period specified by the editorial office.

Proof correction is intended primarily to correct production errors, typographical errors, minor factual inaccuracies, and formatting problems.

Major changes to scientific content, data, conclusions, or authorship after acceptance require editorial approval.

34. Continuous Publication

NOVAXIS follows a continuous publication model. Articles may be published online individually after successful peer review, acceptance, completion of production requirements, and final author approval.

Articles are published individually as soon as they complete peer review and production, and are assigned directly to the journal's annual volume; publication does not wait for a numbered issue.

Each published article becomes part of the permanent scholarly record and receives appropriate bibliographic metadata and persistent identifiers.

35. Open Access and Copyright

NOVAXIS is an open-access journal published by Scientara Publishing, Inc.

Published articles are made freely and permanently available online, allowing readers worldwide to access scholarly content without subscription barriers.

Authors retain copyright subject to the terms of the Creative Commons licence applied by the journal.

Authors should consult the journal's Copyright and Licensing Policy for complete information regarding permitted reuse, distribution, attribution, and licensing conditions.

36. Article Processing Charge

There is no fee for manuscript submission, initial editorial assessment, or peer review.

An Article Processing Charge of USD 300 applies only to manuscripts that have been formally accepted for publication following peer review and final editorial approval.

The Article Processing Charge supports services associated with editorial administration, manuscript processing, copyediting, typesetting, online publication, digital preservation, metadata management and registration, and maintenance of the journal's publishing infrastructure.

Payment is requested only after the manuscript has been formally accepted for publication. Authors are not required to make any payment before an editorial decision has been reached.

Payment of the Article Processing Charge has no influence on manuscript evaluation, peer review, reviewer selection, editorial decisions, or acceptance.

All editorial decisions are based solely on scientific quality, originality, methodological rigour, significance, research integrity, and relevance to the Aims and Scope of NOVAXIS.

37. Waivers and Discounts

Authors who are unable to pay the full Article Processing Charge may contact the NOVAXIS Editorial Office to enquire about possible waiver or discount arrangements.

Requests for waivers or discounts should be handled separately from the editorial and peer-review process and will not influence editorial decisions.

Approval of a waiver or discount is subject to the journal's applicable policy and individual circumstances.

38. Appeals

Authors who believe that an editorial decision was based on a significant factual misunderstanding, procedural error, or demonstrably incorrect interpretation may submit a reasoned appeal to the Editorial Office.

An appeal should address the scientific or procedural basis of the decision rather than simply expressing disagreement with reviewer recommendations.

Appeals are considered at the discretion of the journal and do not guarantee reconsideration or reversal of the original decision.

39. Complaints

Authors, reviewers, readers, and other stakeholders may contact the Editorial Office regarding concerns about editorial procedures, publication ethics, research integrity, conflicts of interest, or other matters related to the journal.

Complaints will be reviewed objectively and handled in accordance with applicable editorial and publishing policies.

40. Corrections, Retractions and Post-Publication Updates

NOVAXIS is committed to maintaining an accurate and reliable scholarly record.

Where an error is identified after publication, the journal may issue a correction or other appropriate notice.

Articles containing major errors, unreliable findings, serious research-integrity problems, plagiarism, duplicate publication, fabricated data, or other circumstances that substantially undermine the reliability of the article may be retracted.

Post-publication notices will be linked transparently to the original article wherever appropriate.

41. Pre-Submission Checklist

Before submitting a manuscript, authors should confirm that:

• the manuscript is appropriate for the Aims and Scope of NOVAXIS;
• the principal scientific or technological contribution is stated clearly;
• the work represents more than an incremental application of established methods;
• the manuscript has not been published previously as a journal article;
• the manuscript is not under consideration by another journal;
• all authors have approved the submitted version;
• the title accurately represents the study;
• the abstract summarises the objective, methods, principal results, and significance;
• 4–8 appropriate keywords have been provided;
• all figures and tables are numbered and cited correctly;
• all figures are of sufficient publication quality;
• all references cited in the manuscript appear in the reference list;
• all entries in the reference list are cited in the manuscript;
• references have been checked for accuracy;
• DOIs have been included wherever available;
• the Data Availability Statement has been provided;
• the Author Contributions Statement has been provided;
• funding sources have been disclosed;
• conflicts of interest have been disclosed;
• ethical approval and informed-consent information have been provided where applicable;
• the use of generative AI has been disclosed where applicable;
• related conference papers, preprints, and previous versions have been disclosed;
• the cover letter explains why the manuscript is suitable for NOVAXIS.

42. Final Submission Responsibility

Submission of a manuscript indicates that the authors have read and accepted these Author Guidelines and the applicable editorial, ethical, copyright, licensing, and publication policies of NOVAXIS.

The corresponding author is responsible for ensuring that all information supplied during submission is complete and accurate and that all co-authors have agreed to submission and publication.

The journal reserves the right to request additional information necessary to verify compliance with editorial, ethical, technical, or research-integrity requirements.

43. Contact

Questions concerning manuscript preparation, journal scope, submission requirements, publication policies, Article Processing Charges, or editorial procedures may be directed to the NOVAXIS Editorial Office at editorial@scientara.org.